{"disease":{"id":"diabetic","name":"diabetic"},"drugs":{"marketed":[{"drug_id":"mirogabalin","indication_name":"Diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tarlige","generic_name":"MIROGABALIN","company_name":"Daiichi Sankyo","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel subunit alpha-2/delta-1","drug_class":"","quality_score":35,"revenue":"300","mechanism":""},{"drug_id":"ranibizumab-eqrn","indication_name":"Diabetic Macular Edema (DME)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CIMERLI","generic_name":"RANIBIZUMAB-EQRN","company_name":"SANDOZ INC","drug_phase":"marketed","molecular_target":"","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"ranibizumab-eqrn","indication_name":"Diabetic Retinopathy (DR)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CIMERLI","generic_name":"RANIBIZUMAB-EQRN","company_name":"SANDOZ INC","drug_phase":"marketed","molecular_target":"","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"lyrica","indication_name":"Neuropathic pain associated with diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"becaplermin","indication_name":"Neuropathic diabetic ulcer - foot","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Regranex","generic_name":"BECAPLERMIN","company_name":"Omj Pharmaceuticals","drug_phase":"marketed","molecular_target":"Platelet-derived growth factor receptor","drug_class":"Human Platelet-derived Growth Factor","quality_score":21,"revenue":null,"mechanism":""},{"drug_id":"metaclopramide","indication_name":"Diabetic gastroparesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metaclopramide","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"irbesartan-hydrochloride","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avapro","generic_name":"IRBESARTAN HYDROCHLORIDE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Avapro works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"esaxerenone","indication_name":"Diabetic nephropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Minnebro","generic_name":"esaxerenone","company_name":"Daiichi Sankyo","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"saroglitazar","indication_name":"Diabetic dyslipidemia associated with type 2 diabetes mellitus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipaglyn","generic_name":"SAROGLITAZAR","company_name":"Cadila Healthcare","drug_phase":"marketed","molecular_target":"Peroxisome proliferator-activated receptor alpha","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"duloxetine","indication_name":"Diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cymbalta","generic_name":"duloxetine","company_name":"Eli Lilly and Company","drug_phase":"marketed","molecular_target":"Serotonin and norepinephrine reuptake","drug_class":"Serotonin and norepinephrine reuptake inhibitor (SNRI)","quality_score":68,"revenue":null,"mechanism":"Potentiates serotonergic and noradrenergic activity in the CNS through unknown exact mechanisms."},{"drug_id":"losartan-potassium","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"LOSARTAN POTASSIUM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":69,"revenue":null,"mechanism":"Cozaar works by blocking the action of angiotensin II on its receptor, which helps to relax blood vessels and lower blood pressure."},{"drug_id":"metoclopramide","indication_name":"Diabetic gastroparesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"METOCLOPRAMIDE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide-hydrochloride","indication_name":"Diabetic gastroparesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"Metoclopramide Hydrochloride","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Acetylcholine receptor sensitization; dopamine antagonism (implied)","drug_class":"Prokinetic agent","quality_score":10,"revenue":null,"mechanism":"Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action."},{"drug_id":"captopril","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Capozide 25/15","generic_name":"CAPTOPRIL","company_name":"Aarxion Anda Hlding","drug_phase":"marketed","molecular_target":"Renin","drug_class":"Thiazide Diuretic [EPC]","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"epalrestat","indication_name":"Diabetic neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eabeth","generic_name":"EPALRESTAT","company_name":"","drug_phase":"marketed","molecular_target":"Aldose reductase","drug_class":"epalrestat","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"piperacillin","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pipracil","generic_name":"PIPERACILLIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"piperacillin","quality_score":10,"revenue":null,"mechanism":"Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death."},{"drug_id":"bat","indication_name":"Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Wound Care in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Wound Care in Wound Care in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Wound Care in Wound Care in Wound Care in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Wound Care in Wound Care in Wound Care in Wound Care in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Wound Care in Wound Care in Wound Care in Wound Care in Wound Care in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"advanced-therapy-only-without-dietary-intervention","indication_name":"Cultured Autologous Tissue-Engineered Skin Substitute for the Treatment of Wound Healing in Wound Care in Wound Care in Wound Care in Wound Care in Wound Care in Wound Care in Diabetic Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advanced therapy only without dietary intervention","generic_name":"advanced-therapy-only-without-dietary-intervention","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various cell types","drug_class":"advanced therapy","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"regranex","indication_name":"Neuropathic diabetic ulcer - foot","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Regranex","company_name":"Solsys Medical LLC","drug_phase":"marketed","molecular_target":"Platelet-derived growth factor receptor","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"lucentis","indication_name":"Diabetic retinopathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lucentis","company_name":"Santen Inc.","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"calcium-dobesilate","indication_name":"Diabetic retinopathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexium","generic_name":"CALCIUM DOBESILATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"calcium dobesilate","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Necrobiosis lipoidica diabeticorum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"losartan","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"losartan","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"AT1 receptor","drug_class":"ARB (Angiotensin II receptor blocker)","quality_score":65,"revenue":null,"mechanism":"Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 receptor."},{"drug_id":"ertapenem","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Invanz","generic_name":"ERTAPENEM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Penem Antibacterial","quality_score":70,"revenue":null,"mechanism":"Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"triamcinolone-hexacetonide","indication_name":"Necrobiosis lipoidica diabeticorum","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aristospan","generic_name":"TRIAMCINOLONE HEXACETONIDE","company_name":"Ethypharm","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"repaglinide","indication_name":"Not for treatment of diabetic ketoacidosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prandin","generic_name":"repaglinide","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family C member 8","drug_class":"Glinide [EPC]","quality_score":10,"revenue":null,"mechanism":"Repaglinide lowers blood glucose levels by stimulating insulin release from the pancreas through ATP-dependent potassium channel blockade."},{"drug_id":"cilastatin","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"olmesartan","indication_name":"diabetic kidney disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"olmesartan medoxomil-hydrochlorothiazide","generic_name":"OLMESARTAN","company_name":"Cosette","drug_phase":"marketed","molecular_target":"","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Olmesartan works by blocking the action of a hormone that causes blood vessels to constrict, allowing blood vessels to relax and blood pressure to decrease."},{"drug_id":"hctz","indication_name":"diabetic kidney disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lisinopril/HCTZ","generic_name":"HCTZ","company_name":"Direct_Rx","drug_phase":"marketed","molecular_target":"","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"linezolid","indication_name":"Diabetic Foot Infection Due to Gram-Positive Bacteria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyvox","generic_name":"linezolid","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] A","drug_class":"Oxazolidinone Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":"Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria."},{"drug_id":"tazobactam","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zosyn","generic_name":"TAZOBACTAM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"beta Lactamase Inhibitor","quality_score":50,"revenue":null,"mechanism":"Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively."},{"drug_id":"irbesartan","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avapro","generic_name":"IRBESARTAN","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"lyrica","indication_name":"Neuropathic pain associated with diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"ranibizumab-nuna","indication_name":"Diabetic retinopathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BYOOVIZ","generic_name":"RANIBIZUMAB-NUNA","company_name":"SAMSUNG BIOEPIS CO LTD","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":41,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04891276","title":"Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk","phase":"","overall_status":"COMPLETED","enrollment_count":3300000,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT04017221","title":"Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":1249636,"lead_sponsor_name":"Canadian Network for Observational Drug Effect Studies, CNODES","has_results":false},{"nct_id":"NCT04240652","title":"The Diabetic Retinopathy Screening, Prevention and Control Program","phase":"","overall_status":"RECRUITING","enrollment_count":500000,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT05966753","title":"Describing Patient With DME, Their Patient Journey and Disease Progression","phase":"","overall_status":"COMPLETED","enrollment_count":221004,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT03579797","title":"Shanghai Diabetic Eye Study in Diabetics","phase":"","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"Shanghai Eye Disease Prevention and Treatment Center","has_results":false},{"nct_id":"NCT00342927","title":"Family Investigation of Nephropathy and Diabetes (F.I.N.D.)","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03752840","title":"Village-Integrated Eye Worker Trial II","phase":"NA","overall_status":"RECRUITING","enrollment_count":60200,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06287645","title":"Color Fundus Photograph With Experts Labelling","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Pakistan Council of Scientific and Industrial Research","has_results":false},{"nct_id":"NCT07308639","title":"DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05527535","title":"Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand","phase":"","overall_status":"UNKNOWN","enrollment_count":34500,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT06250049","title":"Improvement of Diabetic Foot Care in Salamanca Through the Implementation of Standardized Protocols.","phase":"NA","overall_status":"COMPLETED","enrollment_count":25631,"lead_sponsor_name":"Sanidad de Castilla y León","has_results":false},{"nct_id":"NCT06478407","title":"Community Screening Study of Diabetic Retinopathy in Tianjin in 2024","phase":"","overall_status":"RECRUITING","enrollment_count":18000,"lead_sponsor_name":"Li Xiaorong","has_results":false},{"nct_id":"NCT03278587","title":"Village-Integrated Eye Worker Trial II - Pilot","phase":"NA","overall_status":"COMPLETED","enrollment_count":16075,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07497815","title":"Artificial Intelligence-assisted Diagnosis in Ophthalmology","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Marisse Masis-Solano","has_results":false},{"nct_id":"NCT05773495","title":"Implementation of Teleophthalmology in Urban Health Systems Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12840,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT04802395","title":"Real World Evidence Clinical Utility Study of KidneyIntelX","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Renalytix AI, Inc.","has_results":false},{"nct_id":"NCT04544527","title":"The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04935749","title":"Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT03665090","title":"Shanghai Cohort Study of Diabetic Eye Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Shanghai Eye Disease Prevention and Treatment Center","has_results":false},{"nct_id":"NCT06989216","title":"Multi-modal Quantitative Imaging of the Skin","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"HJN Sverige AB/Neko Health","has_results":false},{"nct_id":"NCT06976073","title":"Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"HJN Sverige AB/Neko Health","has_results":false},{"nct_id":"NCT02915198","title":"Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":7410,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT02545049","title":"Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7352,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT07281170","title":"Xinqiao High-risk Cohort of Diabetes(NICE)","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Shanghai General Hospital, China","has_results":false},{"nct_id":"NCT05519163","title":"A Study on Predictive Model for New-onset Diabetic Foot in Type 2 Diabetes Patients.","phase":"","overall_status":"COMPLETED","enrollment_count":6301,"lead_sponsor_name":"Yibing Wang","has_results":false},{"nct_id":"NCT03448029","title":"RECCORD (Recording Courses of Vascular Diseases) Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.","has_results":false},{"nct_id":"NCT06141434","title":"PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05476926","title":"A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04400344","title":"Approaches to Foot Complication Prevention: A Survey of Diabetes Educators","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Podimetrics, Inc.","has_results":false},{"nct_id":"NCT06112431","title":"Eye Health Intervention Study in Upper Manhattan","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5840,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05349955","title":"Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community","phase":"NA","overall_status":"RECRUITING","enrollment_count":5600,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT01858532","title":"Study Of Diabetic Nephropathy With Atrasentan","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":5107,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04327622","title":"Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population","phase":"","overall_status":"COMPLETED","enrollment_count":5084,"lead_sponsor_name":"LMC Diabetes & Endocrinology Ltd.","has_results":false},{"nct_id":"NCT03135327","title":"Clinical Applications of Advanced Ophthalmic Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT06328010","title":"Clinical Registry Collecting Real World Evidence on Wound Care Treatments","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Siddhey LLC","has_results":false},{"nct_id":"NCT03781024","title":"A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Data Collection Analysis Business Management","has_results":false},{"nct_id":"NCT06104969","title":"DFC 004 Biomarkers for Active Diabetic Foot Ulcers","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT03094819","title":"PROTECT2: Diabetes Care - Eye Exam","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Retinal Care Inc.","has_results":false},{"nct_id":"NCT07032116","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4472,"lead_sponsor_name":"Liu Hongfang","has_results":false},{"nct_id":"NCT02065791","title":"Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4401,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT07069647","title":"Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics","phase":"NA","overall_status":"RECRUITING","enrollment_count":4300,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07161947","title":"Shanghai Clinical Cohort of Hyperglycemia in Pregnancy","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Shanghai General Hospital, China","has_results":false},{"nct_id":"NCT04433364","title":"COPE - COVID-19 in Pregnancy and Early Childhood","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3834,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT00001310","title":"Tissue Studies of Human Eye Diseases","phase":"","overall_status":"TERMINATED","enrollment_count":3833,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04624737","title":"Intelligent Evaluation of Diabetic Retinopathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":3183,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03194009","title":"PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3060,"lead_sponsor_name":"Instituto Nacional de Salud Publica, Mexico","has_results":false},{"nct_id":"NCT03978715","title":"The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT06943599","title":"Strategies for Improving Linkage-to-Care After Eye Disease Screening","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03899623","title":"Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT06929143","title":"A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Bayer","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}